FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
LeMaitre Vascular, Inc. Stock AnalysisComprehensive stock analysis for LeMaitre Vascular, Inc. (LMAT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLMAT
LMAT
LeMaitre Vascular, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
LMAT
Home🔹Stocks🔹LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

🇺🇸LMAT•NASDAQ

LeMaitre Vascular, Inc.

🇺🇸LMAT•NASDAQ
Market cap
$1.84B
Sentiment

Your view on LMAT

Mkt Cap
$1.84B
Sentiment
Your view
LMAT
LeMaitre Vascular, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
LMAT
Company Overview

Overview

What the company does, where it operates, and who runs it.

About LeMaitre Vascular, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
George W. LeMaitre
Headquarters
63 Second Avenue, Burlington, MA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
George W. LeMaitre
Headquarters
63 Second Avenue, Burlington, MA, US
Description

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.

It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.

The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin.

In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries.

Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors.

The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for LeMaitre Vascular, Inc., and the rating behind it. LMAT last traded at $80.59, 27.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for LeMaitre Vascular, Inc.. Starting points for LeMaitre Vascular, Inc.: P/E 27.7, EPS $2.87, beta 0.49 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for LeMaitre Vascular, Inc.. LeMaitre Vascular, Inc. paid $0.95 per share over the last year — a 1.2% yield at the current $80.59 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for LeMaitre Vascular, Inc.. Trailing twelve-month EPS for LeMaitre Vascular, Inc. stands at $2.87. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for LeMaitre Vascular, Inc.. LeMaitre Vascular, Inc. has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

LeMaitre Vascular, Inc. valued side by side against its closest peers. LeMaitre Vascular, Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold LeMaitre Vascular, Inc., and how their positions are changing. At a $1.84B market value, institutional positions materially move LeMaitre Vascular, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by LeMaitre Vascular, Inc. executives and directors. Shares of LeMaitre Vascular, Inc. have traded between $71.42 and $109.58 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming LeMaitre Vascular, Inc.. LeMaitre Vascular, Inc. is a $1.84B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming LeMaitre Vascular, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for LeMaitre Vascular, Inc.. Coverage tracks LeMaitre Vascular, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ACHC — Acadia Healthcare Company, Inc.
  • ATRC — AtriCure, Inc.
  • AVAH — Aveanna Healthcare Holdings Inc.
  • HAE — Haemonetics Corporation
  • INSP — Inspire Medical Systems, Inc.
  • NHC — National HealthCare Corporation
  • PAHC — Phibro Animal Health Corporation
  • PRCT — PROCEPT BioRobotics Corporation

More Medical - Instruments & Supplies companies

  • TCGGY — Tecan Group AG
  • TCHBF — Tecan Group AG
  • TDVXF — Tobii Dynavox AB (publ)
  • TFX — Teleflex Incorporated
  • TGLVY — Top Glove Corporation Bhd.
  • TRJ.AX — Trajan Group Holdings Limited
  • TRUMF — Terumo Corporation
  • TRUMY — Terumo Corporation
  • TSNLF — Tristel PLC
  • TUTH — Standard Dental Labs Inc.
  • UTMD — Utah Medical Products, Inc.
  • VSMD — Vasamed, Inc.

ETFs holding LeMaitre Vascular, Inc.

  • DVGR — DAC 3D Dividend Growth ETF (2.55%)
  • MDEV — First Trust Indxx Medical Devices ETF (1.34%)
  • XHE — State Street SPDR S&P Health Care Equipment ETF (1.33%)

News

Latest Market News